The effect of coenzyme Q10 on the pharmacokinetic parameters of theophylline
- 1 July 2008
- journal article
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 31 (7) , 938-944
Abstract
Interaction of a drug with other drugs and dietary supplements is becoming an emerging issue for patients and health insurance authorities due to awareness of adverse drug event. In this study, we examined the effects of coenzyme Q10 (CoQ10), one of the most popular dietary supplements, on the pharmacokinetic parameters of theophylline in rats. The pharmacokinetic parameters of theophylline changed significantly when the drug was administered after five consecutive days of pretreatment with CoQ10. Time to reach maximum plasma concentration of theophylline delayed when the drug was administered after the pretreatment with CoQ10. Maximum plasma concentration and area under the curve of theophylline were about two-fold increased and other pharmacokinetic parameters such as half-life and volume of distribution were also changed significantly. Therefore, although CoQ10 is generally considered a safe dietary supplement, it appears that patients on theophylline therapy should use caution when they take CoQ10.Keywords
This publication has 28 references indexed in Scilit:
- Coenzyme Q10 Supplementation and Heart FailureNutrition Reviews, 2007
- Use of Dietary Supplements Among United States Adults With Coronary Artery Disease and Atherosclerotic RisksThe American Journal of Cardiology, 2007
- Calorie restriction up-regulates the plasma membrane redox system in brain cells and suppresses oxidative stress during agingProceedings of the National Academy of Sciences, 2006
- Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease miceBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2006
- Defining the extent of cables loss in endometrial cancer subtypes and its effectiveness as an inhibitor of cell proliferation in malignant endometrial cells in vitro and in vivoCancer Biology & Therapy, 2005
- Efficacy of Coenzyme Q10 for Improved Tolerability of Cancer Treatments: A Systematic ReviewJournal of Clinical Oncology, 2004
- Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's diseaseExperimental Neurology, 2004
- Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetesEuropean Journal of Clinical Nutrition, 2002
- Effect of alosetron on theophylline pharmacokineticsBritish Journal of Clinical Pharmacology, 2001
- Co‐Enzyme Q10: A New Drug for Cardiovascular DiseaseThe Journal of Clinical Pharmacology, 1990